The candidate should have passed the 10+2 (Class XII) examination or its equivalent from a govt. Approved board/University with Physics and Chemistry as compulsory subjects and any one of the optional subjects : (a) Biology (b) Mathematics (c) Computer science (d) Biotechnology. The Candidates, who have passed 10 + 2 (Science stream) from National Open School (NOS), New Delhi, are not eligible for admission to B.Pharm. Course vised PCI Letter No. 14-2/2007-PCI-13142 dated 27th December 2007.
Admission will be made strictly on the merit of marks obtained in the Entrance Test conducted by Baddi University of Emerging Sciences and Technology.
If the seats remain vacant after exhausting the BUEST Entrance Test merit of marks, the remaining vacant seats will be filled upon the merit of qualifying examination, i.e., 10+2.
Lateral entry seats for admission to 2nd year B. Pharm course will be filled based on the merit of 2nd-year Diploma (Pharm.)
M.Pharmacy :
B. Pharm. from a recognized University with a minimum of 50%.
Admission will be based on merit as determined by the marks scored in BUEST Entrance Examination/GPAT and personal interview.
Total Course Fee Rs. 240000, Duration 2 Year.
Contact Information
Contact Numbers:
01795-247353
Address:
Makhnumajra, Baddi, Solan, Himachal Pradesh, India
Interested in Baddi University School of Pharmacy and Emerging Sciences
Candidates must have passed the 10+2 examination or its equivalent from a recognized Board with PCM subjects as mandatory. Admission will depend on marks scored in Entrance Exams like BUEST, and the remaining seats will be filled on the basis of Merit in the qualifying exam.
Write Your Reviews on "Baddi University School of Pharmacy and Emerging Sciences"
Are you Interested in "Baddi University School of Pharmacy and Emerging Sciences"? Please provide the following details.
Ask Question on "Baddi University School of Pharmacy and Emerging Sciences"?
Know us already? Login here You can login by giving us your login credentials below, or by using a social sign in.